GLP-1 Medicines and Pregnancy: What to Know

Medicines such as semaglutide and tirzepatide can support diabetes care or weight management, but they are not routine pregnancy medicines. If you are pregnant, trying to conceive or could become pregnant, the safest plan is to discuss the exact product with the clinician who prescribes it. Do not stop diabetes treatment without a replacement plan: uncontrolled blood glucose can also harm a pregnancy.

What are GLP-1 medicines?

GLP-1 receptor agonists mimic a hormone involved in appetite, digestion and blood-sugar control. Semaglutide is sold under brands including Ozempic, Wegovy and Rybelsus. Tirzepatide, sold as Mounjaro or Zepbound, acts on both GIP and GLP-1 pathways. Brand names and approved uses vary by country.

These medicines can slow stomach emptying, reduce appetite and improve blood-sugar control. Their effects—and how long they remain in the body—differ by product.

Are GLP-1 medicines safe in pregnancy?

Human pregnancy data remain limited. Current product information generally advises against using GLP-1 medicines for weight loss during pregnancy. Animal studies have raised concerns about fetal harm, but animal findings do not tell us exactly what will happen in a human pregnancy.

Early observational data have not shown a clear increase in birth defects after inadvertent first-trimester exposure, but the numbers studied are still too small to prove safety. This is why an accidental exposure is a reason for prompt, calm medical review—not a reason to assume harm.

Planning a pregnancy

Arrange a preconception appointment before stopping the medicine. Your clinician can help you:

• confirm why you take it and whether another treatment is needed;
• review blood glucose, blood pressure, nutrition and other medicines;
• choose reliable contraception during the advised washout period; and
• plan weight and diabetes care that supports pregnancy without intentional weight loss.

The recommended stopping interval is product-specific. For semaglutide products, current US labeling advises stopping at least two months before a planned pregnancy because the medicine has a long half-life. Other GLP-1 medicines have different clearance times, so do not apply the semaglutide interval to every product.

A special contraception point with tirzepatide

Tirzepatide can reduce the reliability of oral hormonal contraception by delaying stomach emptying, especially when treatment starts or the dose increases. Current US labeling advises switching to a non-oral contraceptive method or adding a barrier method for four weeks after starting tirzepatide and for four weeks after each dose increase.

This warning is specific and important. Ask a clinician or pharmacist whether it applies to your brand, dose schedule and contraceptive method.

What if you become pregnant while taking one?

Contact the prescribing clinician and your maternity or primary-care team promptly. Share the exact product, dose, last dose date, reason for treatment and estimated pregnancy dates. If the medicine was prescribed for diabetes, ask for a safe blood-glucose plan rather than simply going without treatment.

Routine prenatal care already includes screening that checks fetal development. Whether any additional monitoring is appropriate depends on your circumstances and local guidance.

Do GLP-1 medicines improve fertility?

They are not fertility medicines. Weight loss and improved metabolic health may restore ovulation in some people, including some with PCOS/PMOS, which can make pregnancy more likely. That possibility makes contraception and pregnancy planning especially important. It does not prove that the medicine directly improves fertility.

When to seek medical care

Seek urgent assessment for severe or persistent abdominal pain, repeated vomiting with an inability to keep fluids down, signs of dehydration, or symptoms of very high or very low blood sugar. If you have a positive pregnancy test, contact your clinician promptly even if you feel well.

The takeaway

GLP-1 medicines should be part of a planned conversation before pregnancy. The goal is not only to reduce fetal exposure; it is also to keep diabetes, nutrition and overall health safely managed while you prepare to conceive.

This article provides general education and does not replace individualized medical advice. Do not start, stop or change a prescription medicine without advice from a qualified clinician.